EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multiepitope fusion protein-based ELISA for enhanced brucellosis serodiagnosis

Tiansong Zhan, Yan Li, Yujia Xie, Shuangshuang Li, Lili Lian, Wei Han, Dehui Yin iD

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0013804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Tiansong Zhan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Engineering Research Center of Biological Data Mining and Healthcare Transformation, Xuzhou Medical University, Xuzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Brucellosis, Serologic Tests, Epitopes, B-Lymphocyte, Brucella. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: QingLan Project of Jiangsu Province, Postgraduate Research & Practice Innovation Program of Jiangsu Province, Qinglan Project of Jiangsu Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Brucellosis is a widespread zoonotic disease with approximately 2.1 million new human cases annually. Traditional serological methods, which rely on lipopolysaccharide (LPS) as a diagnostic antigen, suffer from cross-reactivity with other Gram-negative bacteria. To address these issues, we aimed to develop a multiepitope fusion protein for improved brucellosis diagnosis.

Methods

We identified linear B-cell epitopes from Brucella proteins using the Immune Epitope Database (IEDB) and constructed a multiepitope fusion protein. The fusion protein was expressed through prokaryotic expression, purified, and was evaluated using an indirect enzyme-linked immunosorbent assay (iELISA) with serum samples from patients with confirmed brucellosis (n = 279) and negative controls from febrile patients (n = 126). To rigorously assess cross-reactivity, it was also tested against a separate panel of sera from 283 non-brucellosis febrile patients with laboratory-confirmed infections by other bacterial pathogens.

Results

The engineered fusion protein, consisting of 11 optimized linear B-cell epitopes derived from the consolidation of 23 initial epitopes obtained from the IEDB, was assessed using iELISA. This evaluation yielded an area under the curve (AUC) of 0.9912 relative to LPS, demonstrating a sensitivity of 95.34% and a specificity of 93.65% in comparison to the negative control group (n = 126). Critically, when tested against the distinct cross-reactivity panel, the fusion protein exhibited cross-reactivity with 9 serum samples from 283 patients infected with other bacterial pathogens, whereas LPS showed cross-reactivity in 41 out of 283 samples.

Conclusions

When evaluated against a clinically relevant control cohort of non-brucellosis febrile patients, the fusion protein demonstrated a substantial advantage by exhibiting significantly lower cross-reactivity compared to LPS, which frequently cross-reacted with other bacterial infections. The multiepitope fusion protein developed in this study demonstrates significant potential as a diagnostic tool for brucellosis. However, the study’s limitations, including a small sample size and lack of information on Brucella species, suggest the need for further research with larger and more diverse sample sets to fully validate its clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrucellosisSerologic TestsEpitopes, B-LymphocyteBrucellaAntibodies, BacterialHumansEnzyme-Linked Immunosorbent AssayRecombinant Fusion ProteinsCross ReactionsSensitivity and SpecificityAntigens, BacterialFemaleMaleAdultMiddle Aged

Substanzen

Epitopes, B-LymphocyteRecombinant Fusion ProteinsAntibodies, BacterialAntigens, Bacterial

Autor:innen und Institutionen

  • Jiangsu Engineering Research Center of Biological Data Mining and Healthcare Transformation, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Shandong Center for Disease Control and Prevention, Jinan, China.
  • Shandong Provincial Key Laboratory of Intelligent Monitoring, Early Warning, and Prevention and control for Infectious Diseases, Jinan, China.
  • Shandong Institute of Preventive Medicine, Jinan, China.
  • Department of Oncology, Heze Municipal Hospital, Heze, China.
  • Department of Laboratory Medicine, First Hospital of Jilin University, Changchun, China.

ORCID-Profile: Dehui Yin

Förderung

  • QingLan Project of Jiangsu Province
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province
  • Qinglan Project of Jiangsu Province of China

Zitieren

APA

Zhan, T., Li, Y., Xie, Y., Li, S., Lian, L., Han, W., & Yin, D. (2025). Multiepitope fusion protein-based ELISA for enhanced brucellosis serodiagnosis. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013804

Vancouver

Zhan T, Li Y, Xie Y, Li S, Lian L, Han W, et al. Multiepitope fusion protein-based ELISA for enhanced brucellosis serodiagnosis. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013804

BibTeX
@article{Zhan2025,
  author = {Zhan, Tiansong and Li, Yan and Xie, Yujia and Li, Shuangshuang and Lian, Lili and Han, Wei and Yin, Dehui},
  title = {Multiepitope fusion protein-based ELISA for enhanced brucellosis serodiagnosis},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0013804}
}
Kostenlos starten →